Viewing Study NCT05600894

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2025-12-26 @ 12:05 AM
Study NCT ID: NCT05600894
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2022-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myelomonocytic Leukemia View
None Myelodysplastic Syndrome View
None Myelodysplastic Syndrome With Excess Blasts View
None Myelodysplastic/Myeloproliferative Neoplasm View
None Myeloproliferative Neoplasm View
Keywords: